MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Antibodies to alpha-Synuclein in Parkinson disease

D. Labunskiy (Santa Rosa, CA, USA)

Meeting: 2018 International Congress

Abstract Number: 1734

Keywords: Immunoglobulins, Inflammation, Parkinsonism

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Pathophysiology

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: Alpha-synuclein (α-syn) plays a very important role in pathogenesis of Parkinson’s disease (PD). There are enough evidence of neuroinflammation in the brain tissue of many neurodegenertive diseases, including PD. Many researchers found lymphocytes and macrophages infiltration in basal ganglia of the brain samples of patients died from PD complications. On the same time, systematical study of α-syn in the brain, serum and CSF of these patient still not performed.

Background: Under our observations were 56 PD patients, 39 men and 17 women, ages from 44 to 83 years old. Control group comprised from 124 healthy donors/ Also we used paraffin slices of cerebellum, brain stem and basal ganglia from patients died from PD complications.

Methods: We produced an enzyme-linked immunosorbent assay (ELISA) for measuring α-syn AAB (IgG) in the serum and CSF of PD patients. Also immunohistochemical study of the brains of 4 patients died from PD. We used antibodies marked by fluorescein-isotiocianate (FITC). Control slices of the brain tissue were taken from person died from PD and from non-neurological causes.

Results: Anti α-syn AAB were increased in 86 percent PD patients, both men -89 per cent and women – 74 per cent) Confocal luminescence was revealed fluorescence in substantia nigra, globus pallidum and locus cereleum in the brain histological samples received from dead PD patients. The histological brain samples from dead patients without any neurological diseases did not revealed any immunofluorescence in basal ganglia or any other brain region.

Conclusions: The studies of immune response in neurodegenerative disorders is a new part of pathogenetic approach to this problem. Antibodies to α-syn probably play an important role in clinical picture and complications of PD.

References: Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson’s Disease Relative to Alzheimer’s Disease and Controls. Shalash A, Salama M, Makar M, Roushdy T1, Elrassas H, Mohamed W, El-Balkimy M, Abou Donia M. Front Neurol. 2017 Dec 22;8:720. doi: 10.3389/fneur.2017.00720. eCollection 2017.

To cite this abstract in AMA style:

D. Labunskiy. Antibodies to alpha-Synuclein in Parkinson disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/antibodies-to-alpha-synuclein-in-parkinson-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/antibodies-to-alpha-synuclein-in-parkinson-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley